A 24-WEEK, DOUBLE-BLIND, RANDOMIZED TRIAL OF FECAL MICROBIOTA TRANSPLANTATION ON MICROBIAL ACQUISITION IN OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Xu, Zhilu
Yang, Keli
Liu, Qin
Tang, Whitney
Zuo, Tao
Li, Amy
Lau, Louis Ho Shing
Lui, Rashid N.
Mak, Joyce Wing Yan
Cheung, Kitty
Ching, Jessica Y.
Wong, Vincent
Wong, Sunny H.
Kong, Alice P. S.
Chow, Elaine Y. K.
Wong, Simon K.
Ho, Ivan Chak Hang
Chan, Paul K.
Chan, Francis K.
Ng, Siew C.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1928
引用
收藏
页码：S483 / S484
页数：2
相关论文
共 50 条
  • [1] Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial
    Ng, Siew C.
    Xu, Zhilu
    Mak, Joyce Wing Yan
    Yang, Keli
    Liu, Qin
    Zuo, Tao
    Tang, Whitney
    Lau, Louis
    Lui, Rashid N.
    Wong, Sunny H.
    Tse, Yee Kit
    Li, Amy Y. L.
    Cheung, Kitty
    Ching, Jessica Y. L.
    Wong, Vincent W. S.
    Kong, Alice P. S.
    Ma, Ronald C. W.
    Chow, Elaine Y. K.
    Wong, Simon K. H.
    Ho, Ivan Chak Hang
    Chan, Paul K. S.
    Chan, Francis K. L.
    [J]. GUT, 2022, 71 (04) : 716 - 723
  • [2] Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial
    Pan, C.
    Yang, W.
    Barona, J. P.
    Wang, Y.
    Niggli, M.
    Mohideen, P.
    Wang, Y.
    Foley, J. E.
    [J]. DIABETIC MEDICINE, 2008, 25 (04) : 435 - 441
  • [3] Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes - A 24-week, double-blind, randomized trial
    Rosenstock, Julio
    Mills, David
    Baron, Michelle A.
    Schweizer, Anja
    Dejager, Sylvie
    [J]. DIABETES CARE, 2007, 30 (02) : 217 - 223
  • [4] Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial
    Schweizer, A.
    Dejager, S.
    Bosi, E.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (08): : 804 - 812
  • [5] Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
    Han, Kyung Ah
    Kim, Yong Hyun
    Kim, Doo Man
    Lee, Byung Wan
    Chon, Suk
    Sohn, Tae Seo
    Jeong, In Kyung
    Hong, Eun-Gyoung
    Son, Jang Won
    Nah, Jae Jin
    Song, Hwa Rang
    Cho, Seong In
    Cho, Seung-Ah
    Yoon, Kun Ho
    [J]. DIABETES & METABOLISM JOURNAL, 2023, 47 (06) : 796 - 807
  • [6] Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: A multicenter, randomized, double-blind, 24-week study
    Otero, ML
    Claros, NM
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (02) : 166 - 173
  • [7] Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    [J]. DIABETES CARE, 2014, 37 (06) : 1650 - 1659
  • [8] Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial
    Halvorsen, Yuan-Di
    Conery, Annie L.
    Lock, John Paul
    Zhou, Wenjiong
    Freeman, Mason W.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2954 - 2962
  • [9] Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial (vol 30, pg 217, 2007)
    Rosenstock, J.
    Baron, M. A.
    Dejager, S.
    Mills, D.
    Schweizer, A.
    [J]. DIABETES CARE, 2007, 30 (05) : 1330 - 1330
  • [10] Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES CARE, 2013, 36 (11) : 3396 - 3404
12345